In this webinar, Stefanie Müthel and Jessica Fiege will discuss how electroporation using the latest technology boosts cell ...

The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein ...

The non-viral transfection reagents market presents growth opportunities driven by the demand for cost-effective, low-immunogenicity alternatives to viral vectors, particularly for nucleic acid-based ...

Asimov has introduced a new manufacturing platform aimed at improving the scalability and consistency of AAV production for gene therapies.

In vivo CD19 CAR T-cell therapy showed promising results in a feasibility study of five patients with refractory systemic ...